Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

RECRUITING NA

Project HOPEFUL: A PN-RCT With Implementation Science

NCT07475039 · View on ClinicalTrials.gov ↗

Study Summary

This PN-RCT replicates and evaluates an 8-week warm calling treatment (i.e. caring contacts) delivered to older adults receiving home and community-based services (HCBS; classified as "homebound") in 20-30 minute call "dosages", across 3 conditions, while adding in implementation science measures at multiple levels. Conditions include 2 treatment (i.e. treatment provided by helpers trained in a standardized and manualized Belongingness and Empathy training grounded in narrative reminiscence and the befriending literature (BE condition), and treatment provided by helpers trained in BE + a standardized, manualized, and evidence based suicide intervention training, the Aging Variant of LivingWorks ASIST (BE + ASIST condition), and 1 control (no treatment during the trial; opportunity to receive treatment after the 8 weeks). At the conclusion of treatment, acceptability, appropriateness, feasibility, useability, and sustainability of the program will be evaluated by interventionists, senior center leadership, and regional leadership.

Interventions

  • BEHAVIORAL Standardized and manualized warm calls from providers trained in the BE training
  • BEHAVIORAL Standardized and manualized warm calls from providers trained in the BE training + ASIST training

Study Locations (1)

Florida

  • University of Florida — Gainesville

Trial Details

FieldValue
Enrollment Target 400 participants
Start Date 2025-09-05
Est. Completion 2030-08-30
Phase NA

Sponsor

University of Florida

1,066 total trials

Interested in This Trial?

Always speak with your doctor before enrolling in a clinical trial.

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT07475039

The ClinicalTrials.gov registry entry for NCT07475039 describes a study currently listed as recruiting. It is categorized as NA, which is the standard way researchers label where a study sits along the investigational pathway from early safety work through later efficacy and post-marketing evaluation. The registered enrollment target is 400 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Florida, which has 1,066 total studies on file at ClinicalTrials.gov, and sponsors are the parties responsible for study design, oversight, and regulatory filings.

The record links to 7 conditions, with Quality of Life appearing as the primary indexed condition, and to 2 interventions — of which Standardized and manualized warm calls from providers trained in the BE training is the first listed. Interventions can include drugs, devices, procedures, behavioral programs, or observational arms, and each is tracked as a separate registry field so that downstream queries can filter accurately. When a trial lists multiple interventions, it usually reflects a multi-arm design or a comparison protocol rather than a single treatment being tested in isolation. The brief summary published in the registry is the clearest source of protocol intent and should be read before drawing conclusions from any sidebar tags.

Geographic footprint matters for practical reasons: NCT07475039 reports 1 study location spanning 1 distinct geographic area — top geographies include Florida. A larger site network tends to correlate with broader recruitment capacity, but it does not imply anything about study quality, and site-level enrollment status can diverge from the overall registry status shown above. Every data point on this page comes from the public ClinicalTrials.gov dataset and is reproduced here for reference only; it is not a medical recommendation, an endorsement of the sponsor, or an invitation to enroll. Verify current status, eligibility criteria, and contact details directly at ClinicalTrials.gov, and discuss any participation decision with your own healthcare provider.

Frequently Asked Questions

What is clinical trial NCT07475039 about?

NCT07475039 is a clinical study titled "Project HOPEFUL: A PN-RCT With Implementation Science". This PN-RCT replicates and evaluates an 8-week warm calling treatment (i.e. caring contacts) delivered to older adults receiving home and community-based services (HCBS; classified as "homebound") in 20-30 minute call "dosages", across 3 conditions, while adding in implementation science measures at...

What is the current status of trial NCT07475039?

This trial is currently recruiting. It is a NA study. The enrollment target is 400 participants. The study started on 2025-09-05. Estimated completion is 2030-08-30.

What conditions does trial NCT07475039 study?

This clinical trial studies the following conditions: Quality of Life, Mental Health, Social Functioning, Depression and Suicide Ideation, Thwarted Belongingness. These conditions were identified from the trial registry and reflect the primary focus areas of the research.

What interventions are being tested in trial NCT07475039?

The interventions under investigation include: Standardized and manualized warm calls from providers trained in the BE training (BEHAVIORAL), Standardized and manualized warm calls from providers trained in the BE training + ASIST training (BEHAVIORAL). Each intervention is being evaluated for safety and efficacy as part of this clinical study.

Who is sponsoring clinical trial NCT07475039?

This trial is sponsored by University of Florida, which has 1,066 total clinical trials registered on ClinicalTrials.gov. The sponsor is responsible for the study's design, funding, and regulatory compliance.

Where is trial NCT07475039 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Related

Data sourced from official U.S. government datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial